Phase IIb study to evaluate the safety and efficacy of topical difluoromethylornithine [eflornithine] and topical diclofenac in the treatment of sun-damaged skin on the forearm
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Eflornithine (Primary) ; Diclofenac
- Indications Skin cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.